Literature DB >> 28648091

Mediators Go Together: High Production of CXCL9, CXCL10, IFN-γ, and TNF-α in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.

Heytor Victor Pereira da Costa Neco1, Vanessa Gabryelle da Silva Teixeira2, Ana Carolina Lemos da Trindade2, Paula Machado Ribeiro Magalhães3, Virgínia Maria Barros de Lorena4, Lúcio Roberto Cançado Castellano5, Joelma Rodrigues de Souza5,6, Luydson Richardson Vasconcelos7, Patrícia Muniz Mendes Freire de Moura2, Clarice Neuenschwander Lins de Morais1.   

Abstract

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic demyelinating and disabling syndrome caused by human T lymphotropic virus 1 (HTLV-1). Although the pathogenic mechanisms that lead to HAM/TSP outcome have not been elucidated, genetic and immunological factors may be involved in the myelopathy occurrence. This study aimed to compare cytokines, chemokines, and nitric oxide (NO) levels in asymptomatic and HAM/TSP HTLV-1-infected patients. The study group consisted of 21 HAM/TSP and 48 asymptomatic HTLV-1 patients. Chemokines (CCL5, CCL2, CXCL8, CXCL9, and CXCL10) and cytokines [IL-2, interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), IL-4, IL-6, and IL-10] were measured using cytometric bead array, whereas NO production was measured after reaction of supernatants with nitrate reduction solution. CXCL9 and CXCL10 chemokines levels were found to be higher in the HAM/TSP group. CXCL9 was also strongly correlated with CXCL10 and both CXCL9 and CXCL10 were moderately correlated with CCL2 and CCL5 levels, in both HAM/TSP and asymptomatic groups. There was no significant difference related to NO, IL-4, IL-6, and IL-10 levels between the clinical groups but TNF-α and IFN-γ levels were increased in HAM/TSP patients. Thus, factors such as CXCL9, CXCL10, TNF-α, and IFN-γ could be good prognostic biomarker candidates, and further studies may help to clarify their association with HAM/TSP immunopathogenesis.

Entities:  

Keywords:  CXCL10; CXCL9; HAM/TSP; HTLV; cytokines; inflammation

Mesh:

Substances:

Year:  2017        PMID: 28648091     DOI: 10.1089/AID.2016.0296

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo.

Authors:  Guangyong Ma; Jun-Ichirou Yasunaga; Koichi Ohshima; Tadashi Matsumoto; Masao Matsuoka
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

2.  Prognosis Markers for Monitoring HTLV-1 Neurologic Disease.

Authors:  Gabriela Prates; Tatiane Assone; Marcelo Corral; Maíra P M Baldassin; Tatiane Mitiko; Flávia C Silva Sales; Michel E Haziot; Jerusa Smid; Luiz A M Fonseca; Fernanda de Toledo Gonçalves; Augusto C Penalva de Oliveira; Jorge Casseb
Journal:  Neurol Clin Pract       Date:  2021-04

Review 3.  Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases.

Authors:  Nicolas Futsch; Gabriela Prates; Renaud Mahieux; Jorge Casseb; Hélène Dutartre
Journal:  Viruses       Date:  2018-12-05       Impact factor: 5.048

Review 4.  Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Yoshiko Nagano; Shuichi Kimpara; Youko Suehiro
Journal:  Retrovirology       Date:  2019-08-22       Impact factor: 4.602

5.  Neurologic, clinical, and immunologic features in a cohort of HTLV-1 carriers with high proviral loads.

Authors:  Sheila N Ferraz; Gabriela F Costa; José Abraão Carneiro Neto; Thiago Hebert; Cassius J V de Oliveira; Mariele Guerra; Lívia M A Oliveira; Edgar M Carvalho
Journal:  J Neurovirol       Date:  2020-05-08       Impact factor: 2.643

6.  Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression.

Authors:  Flávia Dos Santos Souza; Nicole Lardini Freitas; Yago Côrtes Pinheiro Gomes; Rafael Carvalho Torres; Juliana Echevarria-Lima; Isaac Lima da Silva-Filho; Ana Claudia Celestino Bezerra Leite; Marco Antonio Sales Dantas de Lima; Marcus Tulius Teixeira da Silva; Abelardo de Queiroz Campos Araújo; Otávio Melo Espíndola
Journal:  Front Immunol       Date:  2021-10-26       Impact factor: 7.561

7.  Hypovitaminosis D Is Associated with Higher Levels of Inflammatory Cytokines and with HAM/TSP in HTLV-Infected Patients.

Authors:  Elaine Coutinho Netto; Alfredo Carlos Silva; Célia Pedroso; Carlos Brites
Journal:  Viruses       Date:  2021-11-04       Impact factor: 5.818

Review 8.  Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia.

Authors:  Hiba El Hajj; Ali Bazarbachi
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 9.  Influence of Immunogenetic Biomarkers in the Clinical Outcome of HTLV-1 Infected Persons.

Authors:  Antonio Carlos Rosário Vallinoto; Izaura Cayres-Vallinoto; Maria Alice Freitas Queiroz; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2019-10-23       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.